GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Spring Pharmaceutical Group Inc (OTCPK:CYIG) » Definitions » 3-Year Revenue Growth Rate

Spring Pharmaceutical Group (Spring Pharmaceutical Group) 3-Year Revenue Growth Rate : 0.00% (As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is Spring Pharmaceutical Group 3-Year Revenue Growth Rate?

Spring Pharmaceutical Group's Revenue per Share for the three months ended in Mar. 2019 was $0.36.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Spring Pharmaceutical Group's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Spring Pharmaceutical Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spring Pharmaceutical Group's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Spring Pharmaceutical Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Spring Pharmaceutical Group's 3-Year Revenue Growth Rate falls into.



Spring Pharmaceutical Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Spring Pharmaceutical Group  (OTCPK:CYIG) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Spring Pharmaceutical Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Spring Pharmaceutical Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Spring Pharmaceutical Group (Spring Pharmaceutical Group) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Quanxing Road, Sishui County, Shandong Province, Jinan, CHN, 273200
Spring Pharmaceutical Group Inc is a health care company. The company is engaged in the developing, manufacturing and selling innovative traditional Chinese medicines made from panax ginseng leaves extract, developing acer truncatum bunge planting, processing and selling acer truncatum bunge seed oils in the PRC. Some of its product includes Vitality Source Capsule (24 capsules); Vitality Source Capsules (36 capsules); Millet cattle drinking music and others.